☆ 4.6 Article

SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Allergy

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Isabelle Meyts et al.

Summary: The study shows that patients with IEI exhibit varied responses to SARS-CoV-2 infection, with some requiring hospitalization and even intensive care, and a non-negligible mortality rate. In comparison to the general population, younger IEI patients may face a higher risk of severe illness and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde et al.

Summary: SARS-CoV-2-specific T cell epitopes were identified in convalescent and unexposed individuals, showing cross-reactivity with common cold coronaviruses. The diversity of SARS-CoV-2 T cell responses may be associated with mild symptoms of COVID-19.

NATURE IMMUNOLOGY (2021)

添加到收藏夹

Letter Allergy

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-en Ho et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Immunology

PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19

Min-Seok Rha et al.

Summary: Memory T cell responses have been observed in COVID-19 convalescents, with specific T cells showing different phenotypes during the recovery phase. SARS-CoV-2-specific CD8(+) T cells displayed early differentiated effector-memory phenotypes in the early convalescent phase and an increased proportion of stem-like memory cells in the late convalescent phase. Compared to influenza A virus-specific CD8(+) T cells, SARS-CoV-2-specific CD8(+) T cells had a lower frequency of IFN-gamma-producing cells. Additionally, PD-1-expressing SARS-CoV-2-specific CD8(+) T cells were functional rather than exhausted.

IMMUNITY (2021)

添加到收藏夹

Article Allergy

SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency

Sudhir Gupta et al.

Summary: The study examined subsets of CD4+ and CD8+ T cells, B cells, and regulatory lymphocytes in an immunocompetent patient and a CVID patient, revealing different patterns of abnormalities. The immunocompetent patient showed greater changes in various subsets compared to the CVID patient, indicating different immunological responses to SARS-CoV-2 infection.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2021)

添加到收藏夹

Article Allergy

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian M. Shields et al.

Summary: Patients with PID and symptomatic SID have higher morbidity and mortality risks from COVID-19 compared to the general population, requiring enhanced protective measures.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

T Cells: Warriors of SARS-CoV-2 Infection

Paola de Candia et al.

Summary: Severe infection with SARS-CoV-2 is characterized by massive cytokine release and T cell loss. The exaggerated host immune response, possibly dependent on T cell immunological memory, may significantly contribute to immunopathology and massive collateral damage in COVID-19 patients, especially in adults compared with children.

TRENDS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best

Ane Fernandez Salinas et al.

Summary: After BNT162b2 vaccination, some patients with primary antibody deficiencies exhibited atypical immune responses, possibly due to extra-follicular reactions or incomplete germinal center reactions. It remains unknown whether these responses to the vaccine might provide partial protection from infection or reinfection.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel

Nufar Marcus et al.

Summary: The study summarized clinical and laboratory data of PID patients with COVID-19 in Israel, most of whom had mild symptoms, possibly due to their high level of awareness, extra precautions, and even self-isolation. Defects or abnormalities in specific immune pathways, such as type I interferon signaling, might increase the risk of a more severe disease course and the development of COVID-19 sequelae.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency

Hannah Kinoshita et al.

Summary: This study characterized antibody and T cell responses to SARS-CoV-2 structural proteins in patients with antibody deficiencies, showing robust T cell activity and humoral immunity in some patients. The study results are encouraging, especially considering the reliance on spike protein in most candidate vaccines, but further research is needed to define the timing of immunity onset, longevity of immune response, and variability in immunocompromised patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Antibody Responses in COVID-19: A Review

Mateo Chvatal-Medina et al.

Summary: The SARS-CoV-2 continues to spread as a severe pandemic, with variable seroprevalence rates worldwide and higher rates among health workers. The cross-neutralizing response between SARS-CoV and SARS-CoV-2 is controversial, and the use of convalescent plasma has shown uncertain results. Cellular immunity plays a crucial role in resolving the infection.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Allergy

Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity

Cinzia Milito et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Allergy

Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity

David Hagin et al.

Summary: The study evaluated the humoral and cellular immune response to the COVID-19 vaccine in patients with IEI, finding that most patients were able to develop vaccine-specific antibody response and S-protein-specific cellular response, and no significant adverse events were reported during the vaccination process.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico

Lina M. Castano-Jaramillo et al.

Summary: Most patients with IEI in Mexico who acquired SARS-CoV-2 infection had a well-tolerated infection and survived, with a survival rate of over 80%. Children had a higher hospital admission rate than adults, while the ICU mortality rate was relatively high.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Letter Immunology

COVID-19 in Patients with Primary Immunodeficiency

Saliha Esenboga et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Erin M. Bange et al.

Summary: In patients with cancer and COVID-19, those with hematologic cancer show impaired immune responses compared to solid cancer patients. CD8 T cells play a crucial role in survival, even in the presence of limited humoral responses. The presence of SARS-CoV-2-specific T cell responses in hematologic cancer patients suggests a potential therapeutic target.

NATURE MEDICINE (2021)

添加到收藏夹

Article Immunology

Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Stuart P. Weisberg et al.

Summary: This study found distinct antibody responses in children and adults after SARS-CoV-2 infection. Adult COVID-19 cohorts showed a broader range of antibody responses, while children predominantly generated antibodies specific for the S protein and had reduced neutralizing activity compared to adults.

NATURE IMMUNOLOGY (2021)

添加到收藏夹

Letter Immunology

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Hong-Yi Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Ling Ni et al.

IMMUNITY (2020)

添加到收藏夹

Article Allergy

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia

Isabella Quinti et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Review Immunology

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art

Gabriel Siracusano et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Allergy

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Annarosa Soresina et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

添加到收藏夹

Review Immunology

Cell-Mediated Immune Responses to COVID-19 Infection

Amelie Guihot et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Daniela Weiskopf et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Alessio Mazzoni et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert et al.

NATURE (2020)

添加到收藏夹

Article Immunology

Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients

Youenn Jouan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

添加到收藏夹

Article Immunology

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Matthew C. Woodruff et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

Sophie Steiner et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases

Rita Carsetti et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

Fan Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Immunology

T cell responses in patients with COVID-19

Zeyu Chen et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.